Myovista iECG for Detecting Ischemic Heart Disease: Comparison With Computed Tomography Coronary Angiography
Sponsored by Cardiocentro Ticino
About this trial
Last updated 14 years ago
Study ID
HTL-01-11
Status
Unknown
Type
Observational
Placebo
No
Accepting
All Ages
All Sexes
Trial Timing
Ended 13 years ago
What is this trial about?
Study evaluates the new technique MyoVista™ iECG sensitivity and ability to predict myocardial diseases, comparing iECG results with Computed Tomography Coronary Angiography findings
What are the participation requirements?
Inclusion Criteria
* chest pain,
* shortness of breath,
* syncope or equivocal stress testing including exercise ECG,
* myocardial perfusion imaging, or stress echocardiography unable to exclude significant coronary artery disease.
* All patients will provide written and oral consent to CTCA.
* Patient agrees to participate and signs the informed consent
Exclusion Criteria
* usually renal insufficiency (serum creatinine >120 mol/l),
* contraindications to the administration of iodinated contrast,
* pregnancy, acute coronary syndromes,
* and ventricular and/or supraventricular arrhythmias.